Modern features of epidemiology of genital herpes

Abstract

The specific weight of genital herpes caused by the herpes simplex virus of the first and / or the second type is evaluated. The features of the risk factors for genital herpes are analyzed depending on the type of the virus. It is established that at present there is a tendency to form an interlayer of patients (18,5%), in whom genital herpes is caused by the herpes simplex virus of the first type. This virus is most often detected in patients under the age of 30, mostly women (80%) who are on the early stage of the disease (57%). Patients with genital herpes who have a herpes simplex virus of the first type are less likely to be married, are more likely to have casual sex, more often indicate a lack of a regular sexual partner, are less likely to be in a relationship with a partner for less than 2,5 years. More than half of patients with genital herpes do not attach importance to the presence of their disease. However, most of them are afraid to infect a sexual partner and are ready to receive long-term, including suppressive, therapy to prevent relapses. However, most patients are not aware of the genital herpes status of the sexual partner. The main risk factors for genital herpes caused by the herpes simplex virus of the first and second types are generally similar – female sex, young age, lack of a regular sexual partner and the presence of random sexual intercourse. However, the probability of infection with the herpes simplex virus of the first type among women of a young age is higher than that of the second type of herpes simplex virus.

Keywords

genital herpes / herpes simplex virus / risk factors / anonymous questioning / sexual behavior / orogenital contacts / suppressive therapy

References

[1] Василишина, И.Ю. Оптимизация лечения генитального герпеса у женщин репродуктивного возраста: дис. … канд. мед. наук // И.Ю. Василишина. – М.: МГМСУ, 2006. – 87 с.

[2] Семенова, Т.В. Эпидемиологические аспекты генитального герпеса, Т.В. Семенова [и др.] // Анализ заболеваемости генитальным герпесом в Российской Федерации и в г. Москве за период с 1994 по 1998 г. – М., 2000. № 6. – С. 26–30.

[3] Федеральные клинические рекомендации Российского общества дерматовенерологов и косметологов, 2015: Болезни кожи. Инфекции, передаваемые половым путем. – 5-е изд., перераб. и доп. – М.: Деловой экспересс, 2016. – С. 655–664.

[4] Хальфин, Р.А. Методические рекомендации «Анализ эпидемиологической ситуации по ВИЧ-инфекции и сопутствующим заболеваниям (туберкулез, ИППП, гепатиты) / Р.А. Хальфин // Приказ № 6964 от 20.09. 2007 г. – М., 2007. – 26 с.

[5] Чеботарев, В.В. Герпесвирусная и папилломавирусная инфекции / В.В. Чеботарев [и др.]. – Ставрополь: Седьмое небо, 2013. – 9 с.

[6] Bernstein, D.I. Epidemiology, Clinical Presentation, and Antibody Response to Primary Infection With Herpes Simplex Virus Type 1 and Type 2 in Young Women. D.I. Bernstein [et al.] // Clin Infect Dis. – 2013. – Vol. 56, № 3. – P. 344–351.

[7] Chentoufi, A.A. Mucosal Herpes Immunity and Immunopathology to Ocular and Genital Herpes Simplex Virus Infections. A.A. Chentoufi [et al.] // Clinical and Developmental Immunology. – 2012. – Vol. 10. – P. 149–135.

[8] Corey, L. Once-Daily Valacyclovir to Reduce the Risk of Transmission of Genital Herpes. L. Corey [et al.] // N. Engl. J. Med. – 2004. – Vol. 350. – P. 11–20.

[9] Fatahzadeh, M. Human herpes simplex virus infections: Epidemiology, pathogenesis, symptomatology, diagnosis, and management. M. Fatahzadeh [et al.] // J. Am. Acad. Dermatol. – 2007. – Vol. 57. – Р. 737–763.

[10] Garceau, R. Herpes simplex virus type 1 is the leading cause of genital herpes in New Brunswick / R. Garceau [et al.] // Can. J. Infect. Dis Med. Microbiology. – 2012. – Vol. 23. – № 1. – P. 15–18.

[11] Je Vries, D. Issues in herpes management / D. Je Vries [et al.] // Antiviral. Chem. Chemother. – 1994. – Vol. 5. – P. 9–23.

[12] Kristen, C. Penуеal. Genital herpes simplex virus type 1 in women: detection in cervicovaginal specimens from gynecological practices in the United States / C. Penуеal Kristen [et al.] // J. Clin. Microbiol. – 2010. – Vol. 48. – P. 150–153.

[13] Lafferty, W.E. Herpes simplex type 1 as a cause of genital herpes: impact on surveillance and prevention / W.E. Lafferty [et al.] // J. Infect. Dis. – 2000. – Vol. 181, № 7. – P. 1454.

[14] Langenberg, A.G. A prospective study of new infections with herpes simplex virus type 1 and type 2. Chiron HSV Vaccine Study Group / A.G. Langenberg [et al.] // N. Engl. J. Med. – 1999. – Vol. 341, № 8. – P. 1432.

[15] Looker, K.J. A systematic review of the epidemiology and interaction of herpes simplex virus types 1 and 2 / K.J. Looker [et al.] // Sex Transm Infections. – 2005. – Vol. 81, № 2. – P. 103–107.

[16] Lowhagen, G.B. First episodes of genital herpes in a Swedish STD population: a study of epidemiology and transmission by the use of herpes simplex (HSV) typing and specific serology / G.B. Lowhagen [et al.] // Sex Transm Infect. –2000. – Vol. 76. – P. 82.

[17] Patel, R. Impact of suppressive antiviral therapy on the health related quality of life of patients with recurrent genital herpes infection / R. Patel [et al.] // Sex Transm Inf. – 1999. – Vol. 75. – P. 398–402.

[18] Pebody, R.G. The seroepidemiology of herpes simplex virus type 1 and 2 in Europe / R.G. Pebody [et al.] // Sex Transm Infect. – 2004 – Vol. 80. – P. 185–191.

[19] Ross, J. The epidemiology of herpes simplex types 1 and 2 infection of the genital tract in Edinburgh / J. Ross [et al.] // Genitourin Med. – 1993. – Vol. 69, № 3. – P. 381.

[20] Xu, F. Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States / F. Xu // JAMA. – 2006. – Vol. 296, № 8. – P. 964–973.

RIGHTS & PERMISSIONS

Eco-Vector